Related Experiment Video
Updated: Jun 5, 2026
10:45
Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
Severe hypertriglyceridemia influenced by alcohol (SHIBA)
Kirsten Bessembinders1, Jos Wielders, Albert van de Wiel
1Department of Internal Medicine, Meander Medical Centre, Amersfoort, The Netherlands.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|January 20, 2011
Summary
Excessive alcohol consumption is a significant factor in severe hypertriglyceridemia (HT). Patients with high triglyceride levels, especially those with obesity and diabetes, should monitor alcohol intake to prevent severe health risks.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Cardiovascular Health
Background:
- Severe hypertriglyceridemia (HT) is a critical condition requiring identification of contributing factors.
- Understanding the role of lifestyle, particularly alcohol consumption, is vital for managing HT.
Purpose of the Study:
- To investigate the association between excessive alcohol intake and triglyceride (TG) levels in patients diagnosed with severe HT.
- To identify risk factors contributing to severe hypertriglyceridemia.
Main Methods:
- Retrospective analysis of medical records for 300 patients with TG levels exceeding 11.3 mmol/l.
- Assessment of alcohol consumption patterns and other risk factors for HT.
Main Results:
- Excessive alcohol consumption was identified in 24% of patients with severe HT, rising to 43% in the highest TG quartile.
- Significantly higher TG levels were observed in excessive alcohol drinkers (P < 0.001).
- Acute pancreatitis occurred in 4% of the cohort, exclusively in patients with very high TG levels.
Conclusions:
- Excessive alcohol consumption is a prevalent risk factor in a quarter of severe HT cases.
- The combination of obesity, diabetes mellitus, and excessive alcohol intake significantly elevates TG levels, increasing pancreatitis risk.
Related Concept Videos
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...